Cutaneous COVID-19 vaccine reactions tops 2021 dermatology news
Click Here to Manage Email Alerts
The rollout of three COVID-19 vaccines has begun to ease the burden the virus has on U.S. hospitals and death rates; however, a small number of people have experienced cutaneous reactions to the vaccine, including those with facial fillers.
That article was the most-read dermatology-related news on Healio in 2021.
More COVID-19-related news also dominated our readers’ interest, along with trending topics and product recalls.
Here are the top 10 most-read dermatology articles of 2021:
Q&A: Reaction to facial fillers may be seen with Moderna COVID-19 vaccine
Adverse events recorded in phase 3 trials of the COVID-19 vaccine developed by Moderna have included facial swelling in patients who have previously received facial fillers. Read more.
Delayed cutaneous reaction to COVID-19 vaccine should not preclude further vaccinations
The delayed reaction, called “COVID arm,” occurred 2 to 12 days after the vaccination and consisted of pruritic and painful erythematous skin near the injection site lasting a median of 5 days. Read more.
National Psoriasis Foundation recommends COVID-19 vaccine in pandemic guidelines
The guidelines, published in Journal of the American Academy of Dermatology, were developed by a task force of 18 dermatology, rheumatology, epidemiology, infectious diseases and critical care physicians. Read more.
Gorilla Glue hair incident could cause long-term damage, experts warn
The story of a woman using industrial strength glue in her hair has gone viral, spawning comments and criticism from across the world, but some experts warn that these types of actions can lead to serious, long-term damage. Read more.
Cutaneous reactions to Pfizer, Moderna COVID-19 vaccines minor
Cutaneous reactions to the mRNA-based COVID-19 vaccines were mostly minor and self-limited and should not discourage individuals from receiving a vaccine, according to a study. Read more.
Johnson & Johnson recalls Neutrogena, Aveeno aerosol sunscreens
The company is voluntarily recalling Neutrogena Beach Defense, Cool Dry Sport, Invisible Daily Defense and Ultra Sheer aerosol sunscreens, as well as Aveeno Protect + Refresh at the consumer level, according to the release. Read more.
COVID-19 vaccine effects on immune-mediated inflammatory diseases should be understood
There are currently two mRNA vaccines and one adenovirus-based vaccine approved for emergency use in the United States. For patients with IMIDs, the mRNA vaccines may trigger an inflammatory response, while the adenoviral vector vaccine may carry a rare risk for thrombosis. Read more.
FDA proposes updates to sunscreen requirements
The proposed revisions include updates to the maximum sun protection factor (SPF) values, active ingredients, broad spectrum requirements and product labeling. Read more.
Granuloma annulare more likely to affect white middle-aged women
Using data from the Optum Clinformatics Data Mart database, the retrospective cross-sectional study identified 11,608 patients with incident granuloma annulare and 17,862 with prevalent granuloma annulare. Female patients made up 74.8% and 75.8% of the two groups, respectively. Read more.
Biologics not associated with COVID-19 risk or mortality
The retrospective matched cohort study, detailed in a brief report in the Journal of the American Academy of Dermatology, included 7,361 patients who received biologics and 74,910 matched controls. Read more.